An overview of Sirtuins as potential therapeutic target: Structure, function and modulators

Yijie Wang,Jun He,Mengya Liao,Mingxing Hu,Wenzhen Li,Hongling Ouyang,Xin Wang,Tinghong Ye,Yiwen Zhang,Liang Ouyang
DOI: https://doi.org/10.1016/j.ejmech.2018.10.028
IF: 7.088
2019-01-01
European Journal of Medicinal Chemistry
Abstract:Sirtuin (Yeast Silent Information RegulatorsⅡ, Sir2) was first discovered in the 1970s. Because of its function by removing acetylated groups from histones in the presence of nicotinamide adenine dinucleotide (NAD+), waves of research have assessed the potential of Sirtuin as a therapeutic target. The Sirtuin family, which is widely distributed throughout the nature, has been divided into seven human isoforms (Sirt1-Sirt7). They are thought to be closely related to some aging diseases such as cardiovascular disorders, neurodegeneration, and tumors. Herein, we present a comprehensive review of the structure, function and modulators of Sirtuins, which is expected to be beneficial to relevant studies.
What problem does this paper attempt to address?